The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Delineation of MGMT promoter hypermethylation as a predictive biomarker for the A071102 clinical trial of veliparib combined with temozolomide (TMZ) using patient-derived xenograft (PDX) GBM models.
 
Jann Nagina Sarkaria
Research Funding - Basilea; BeiGene; Genentech; Lilly; Sanofi
 
Shiv Gupta
No Relationships to Disclose
 
Sani Haider Kizilbash
No Relationships to Disclose
 
Brett Carlson
No Relationships to Disclose
 
Ann Mladek
No Relationships to Disclose
 
Katrina Bakken
No Relationships to Disclose
 
Mark A Schroeder
No Relationships to Disclose
 
Paul A. Decker
No Relationships to Disclose
 
Erik P. Sulman
No Relationships to Disclose
 
Jeanette Eckel-Passow
No Relationships to Disclose
 
Gaspar Kitange
No Relationships to Disclose
 
Robert B. Jenkins
Patents, Royalties, Other Intellectual Property - Royalites from Abbott Molecular; Royalties from Genome Diagnostics Inc; Royalties from Genome Diagnostics Inc